Connect with us

Business

CSL (ASX:CSL) share price wobbles on COVID vaccine news – The Motley Fool Australia

The CSL Limited (ASX: CSL) share price is on watch after the UK found “possible links” between the AstraZeneca vaccine and blood clots.

Published

on

Article feature image

The CSL Limited (ASX: CSL) share price is a little wobbly this morning after negative vaccine news overnight from the United Kingdom.
The pharmaceutical giant, which produces and supplies the AstraZeneca PLC (LSE: AZ)COVID-19 vaccine in Australia, is trading close to its opening price after news that the UK medical regulator has found a “possible link” between the vaccine and blood clotting in younger adults. The regulator noted that blood clotting was considered a rare side-effect of the vaccine.

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

5 things to watch on the ASX 200 on Monday 19 April 2021
Article feature image
Tesla with ‘no one’ driving crashes, killing two – Sydney Morning Herald